Form 4: Medicus Pharma Executive Receives Stock Grant
Insider Transaction (Form 4)
Edward J. Brennan, Chief Scientific Officer of Medicus Pharma Ltd., reported multiple transactions in common stock on September 4, 2026.
Summary
- Grant/award: acquired 588,235 Common Shares, no par value at $0.17 ($100,294) on September 4, 2026; holds 674,735 after (Direct).
- Grant/award: acquired 100,000 Stock Option (right to buy) on September 4, 2026; holds 100,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Edward J. Brennan — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Grant/award | Common Shares, no par value | 588,235 | $0 | $100.3K | 674,735 |
| 2026-09-04 | Grant/award | Stock Option (right to buy) | 100,000 | — | — | 100,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Grant/award (588,235 shares) |
| 2026-09-04 | Grant/award (100,000 shares) |
Keywords
insider transaction, Form 4, MDCX, Medicus Pharma Ltd., neutral, Edward J. Brennan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.